/Companies

Tolera Therapeutics

Kalamazoo, US · 1 known investors

Find your way into Tolera Therapeutics

Sign up to see every warm intro you have to Tolera Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Tolera Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

AP
Ashleigh PalmerExecutive

Board

MO
Mark OlesnavageBoard director
SD
Suzette DutchBoard director
DP
Donald ParfetBoard director
DM
Douglas MortonBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$250K disclosed across 1 round · 2014

▶$250KraisedSep 2014 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas MortonDirector
  • Mark OlesnavageDirector
  • Suzette DutchDirector
  • Donald ParfetDirector
  • Ashleigh PalmerExecutive Officer
Amount sold
$250K
Minimum investment
$1K
First sale
Sep 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Tolera Therapeutics's investors?
Tolera Therapeutics's investors include Triathlon Medical Venture Partners.
How much funding has Tolera Therapeutics raised?
Tolera Therapeutics has disclosed $250K raised across 1 round.
Where is Tolera Therapeutics headquartered?
Tolera Therapeutics is headquartered in Kalamazoo, US.